September 3, 2012 |
On the day before a doctor is expected to tell him whether his season is over, Dodgers closer Kenley Jansen said he was calm. "Whatever the fact is, I will accept it," Jansen said. "You have to take care of your health first. " Jansen has taken blood thinners since he was hospitalized last week for treatment of an irregular heartbeat. If the doctor determines the blood thinners have resolved the issue, Jansen will be taken off the medication and could return as soon as Friday.
May 9, 2012 |
New York Yankees closer Mariano Rivera has a blood clot in his right calf and is on blood thinners to dissolve the clot. The problem was discovered while he was being examined after injuring his knee during batting practice last week. Rivera will spend at least a week or two strengthening his knee before he has surgery for a torn anterior cruciate ligament, but he says that would have been the case regardless of the blood clot. Last week, Rivera said he was touched by the outpouring of support he received after the knee injury.
March 9, 2012 |
Dabigatran (marketed as Pradaxa) is a new drug used by a growing number of Americans with atrial fibrillation. It's both easier to take and more effective at reducing the risk of stroke than warfarin, a drug that's been in use since the 1950s. But a case report published this week underscores a danger with the new medication: If a patient taking it is bleeding into the brain or elsewhere, there is currently no fast, effective way to reverse the blood-thinning agent's effects. For one 83-year-old man who was taken to the University of Utah Hospital's emergency department after falling and hitting his head, the result was death.
February 16, 2012 |
As many as one-third of women with ovarian cancer have high levels of platelets in their blood, which is linked to worse outcomes, researchers reported Wednesday. Platelets are components of cells that clump together to stop bleeding. Having an excessively high level of platelets is called thrombocytosis. Doctors have long known that thrombocytosis is associated with cancer. In the new study, published in the New England Journal of Medicine , researchers at M.D. Anderson Cancer Center in Houston analyzed data from 619 women with ovarian cancer.
February 9, 2011 |
Drug interactions can lead to serious problems. Even taking something as seemingly benign as an over-the-counter cold medication could lead to an unpleasant, or dangerous, interaction with a so-routine-you-don't-even-think-about-it prescription drug. This panel of pharmacists can help sort out what drugs cause reactions and how to avoid unwanted ones. A live Web chat Thursday (noon EST, 11 a.m. CST, 9 a.m. PST) will feature Stefanie C. Nigro, assistant clinical professor at the University of Connecticut School of Pharmacy; Laura Hobbs, pharmacy clinical coordinator and director of the pharmacy residency program at Hartford Hospital; and Flora Harp, community practice resident for CVS/pharmacy.
November 18, 2010 |
Pfizer Inc. and Bristol-Myers Squibb said late Thursday that they were terminating a study of the experimental blood thinner apixaban prematurely because the drug was showing no benefits and was producing excess bleeding among patients receiving it. The study, called APPRAISE-2, was testing the drug in 10,800 patients with acute coronary syndrome, a group of problems characterized by chest pain caused by insufficient blood supply to the heart muscle....